$50,000 of AECOM lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Project development and engineering contracts Project development and engineering contracts Project development and engineering contracts"
You can find more data on corporate lobbying on Quiver Quantitative.
ACM Insider Trading Activity
ACM insiders have traded $ACM stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ACM stock by insiders over the last 6 months:
- LARA POLONI (PRESIDENT) has made 0 purchases and 2 sales selling 17,533 shares for an estimated $1,701,134.
- DAVID Y. GAN (CHIEF LEGAL OFFICER) has made 0 purchases and 2 sales selling 15,502 shares for an estimated $1,514,889.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ACM Hedge Fund Activity
We have seen 256 institutional investors add shares of ACM stock to their portfolio, and 357 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 6,691,242 shares (-70.7%) from their portfolio in Q4 2025, for an estimated $637,876,099
- ALLIANCEBERNSTEIN L.P. removed 1,090,671 shares (-41.8%) from their portfolio in Q4 2025, for an estimated $103,973,666
- PICTET ASSET MANAGEMENT HOLDING SA removed 849,546 shares (-22.5%) from their portfolio in Q4 2025, for an estimated $80,987,220
- CI INVESTMENTS INC. removed 846,658 shares (-73.2%) from their portfolio in Q4 2025, for an estimated $80,711,907
- INVESCO LTD. removed 663,317 shares (-13.3%) from their portfolio in Q4 2025, for an estimated $63,234,009
- FMR LLC removed 629,994 shares (-34.7%) from their portfolio in Q4 2025, for an estimated $60,057,328
- BLACKROCK, INC. added 521,689 shares (+3.6%) to their portfolio in Q4 2025, for an estimated $49,732,612
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ACM Analyst Ratings
Wall Street analysts have issued reports on $ACM in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 01/21/2026
- Truist Securities issued a "Buy" rating on 11/21/2025
- Argus Research issued a "Buy" rating on 11/20/2025
- RBC Capital issued a "Outperform" rating on 11/20/2025
- Barclays issued a "Overweight" rating on 11/20/2025
- Citigroup issued a "Buy" rating on 11/19/2025
To track analyst ratings and price targets for ACM, check out Quiver Quantitative's $ACM forecast page.
ACM Price Targets
Multiple analysts have issued price targets for $ACM recently. We have seen 9 analysts offer price targets for $ACM in the last 6 months, with a median target of $132.0.
Here are some recent targets:
- Adam Seiden from Barclays set a target price of $110.0 on 02/11/2026
- Jamie Cook from Truist Securities set a target price of $132.0 on 02/11/2026
- Sabahat Khan from RBC Capital set a target price of $142.0 on 02/11/2026
- Michael Feniger from B of A Securities set a target price of $118.0 on 02/10/2026
- Steven Fisher from UBS set a target price of $145.0 on 02/10/2026
- Adam Bubes from Goldman Sachs set a target price of $127.0 on 01/28/2026
- Andrew Kaplowitz from Citigroup set a target price of $131.0 on 01/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
